Gambling and substance use: Comorbidity and treatment implications

被引:51
作者
Grant, Jon E. [1 ]
Chamberlain, Samuel R. [2 ,3 ]
机构
[1] Univ Chicago, Dept Psychiat & Behav Neurosci, Chicago, IL 60637 USA
[2] Univ Cambridge, Dept Psychiat, Cambridge, England
[3] Cambridge & Peterborough NHS Fdn Trust CPFT, Cambridge, England
基金
英国惠康基金;
关键词
NATIONAL EPIDEMIOLOGIC SURVEY; ALCOHOL-USE DISORDER; DEFICIT HYPERACTIVITY DISORDER; IMPULSE CONTROL DISORDERS; PLACEBO-CONTROLLED TRIAL; PATHOLOGICAL GAMBLERS; GENDER-DIFFERENCES; GENETIC VULNERABILITY; BEHAVIORAL TREATMENTS; BRIEF INTERVENTIONS;
D O I
10.1016/j.pnpbp.2019.109852
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Gambling disorder is a common condition that was previously listed as an impulse control disorder, but is now considered a substance-related and addictive disorder. Gambling disorder has been associated with various untoward long-term outcomes including impaired quality of life, relationship break-ups, debt and mortgage foreclosure, and elevated risk of suicidality. This paper provides a concise primer on gambling disorder, with a special focus on its parallels with substance use disorders. We consider clinical presentations, comorbid expression, heritability, and treatment approaches (psychological and pharmacological). Lastly, we highlight new treatment directions suggested by the literature.
引用
收藏
页数:6
相关论文
共 50 条
  • [41] Using rodent models to understand interactions between gambling and substance use
    Setlow, Barry
    Blaes, Shelby L.
    Burns, Matthew R.
    Dragone, Richard J.
    Orsini, Caitlin A.
    [J]. CURRENT OPINION IN BEHAVIORAL SCIENCES, 2020, 31 : 37 - 41
  • [42] Common neurobiological and psychological underpinnings of gambling and substance-use disorders
    Balodis, Iris M.
    Potenza, Marc N.
    [J]. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2020, 99
  • [43] The Heterogenous Nature of Substance Use and Substance Use Disorders: Implications for Characterizing Substance-Related Stigma
    Sher, Kenneth J.
    [J]. PSYCHOLOGICAL SCIENCE IN THE PUBLIC INTEREST, 2023, 24 (02) : 82 - 89
  • [44] Delay Discounting in Gambling Disorder: Implications in Treatment Outcome
    Mena-Moreno, Teresa
    Testa, Giulia
    Mestre-Bach, Gemma
    Miranda-Olivos, Romina
    Granero, Rosario
    Fernandez-Aranda, Fernando
    Menchon, Jose M.
    Jimenez-Murcia, Susana
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (06)
  • [45] Substance use disorders and psychiatric comorbidity in mid and later life: a review
    Wu, Li-Tzy
    Blazer, Dan G.
    [J]. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2014, 43 (02) : 304 - 317
  • [46] Molecular Imaging Genetics of Methylphenidate Response in ADHD and Substance Use Comorbidity
    Szobot, Claudia M.
    Roman, Tatiana
    Hutz, Mara H.
    Genro, Julia P.
    Shih, Ming Chi
    Hoexter, Marcelo Q.
    Junior, Neivo
    Pechansky, Flavio
    Bressan, Rodrigo A.
    Rohde, Luis A. P.
    [J]. SYNAPSE, 2011, 65 (02) : 154 - 159
  • [47] A network approach to substance use, internalizing, and externalizing comorbidity in US adults
    Blondino, Courtney T.
    Prom-Wormley, Elizabeth C.
    [J]. ADDICTIVE BEHAVIORS, 2022, 134
  • [48] Network Analysis of DSM Symptoms of Substance Use Disorders and Frequently Co-Occurring Mental Disorders in Patients with Substance Use Disorder Who Seek Treatment
    Lopez-Toro, Edith
    Wolf, Casper J. H.
    Gonzalez, Rafael A.
    van den Brink, Wim
    Schellekens, Arnt
    Velez-Pastrana, Maria C.
    [J]. JOURNAL OF CLINICAL MEDICINE, 2022, 11 (10)
  • [49] Comorbidity of substance use disorders and attention-deficit hyperactivity disorders
    Fallgatter, A. J.
    Jacob, C. P.
    [J]. NERVENARZT, 2009, 80 (09): : 1015 - +
  • [50] Use of Gabapentin in the Treatment of Substance Use and Psychiatric Disorders: A Systematic Review
    Ahmed, Saeed
    Bachu, Ramya
    Kotapati, Padma
    Adnan, Mahwish
    Ahmed, Rizwan
    Farooq, Umer
    Saeed, Hina
    Khan, Ali Mahmood
    Zubair, Aarij
    Qamar, Iqra
    Begum, Gulshan
    [J]. FRONTIERS IN PSYCHIATRY, 2019, 10